Clinical Drug Experience Knowledgebase

Lymphoma, Mantle-Cell

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Communicable Diseases (Phase 1)

Glioblastoma (Phase 2)

Hepatic Insufficiency (Phase 1)

Infections (Phase 1)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Leukemia, Prolymphocytic (Phase 2)

Liver Diseases (Phase 1)

Liver Failure (Phase 1)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Mantle-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 1)

Multiple Myeloma (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 1)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Syndrome (Phase 2)

Waldenstrom Macroglobulinemia (Phase 2)